The Vancouver Prostate Centre has responded, along with many in the local Life Sciences community, by donating our inventory of personal protective equipment (PPE) and cleaning products to frontline workers engaged in the fight against COVID-19.
We thank the Vancouver Coastal Health Research Institute for coordinating this effort at VCH research sites, and we thank Life Sciences BC and Xenon for coordinating with health authority partners and the BC Centre for Disease Control for collection and distribution.
Vancouver, B.C. (March 16, 2020): An Artificial Intelligence (AI) platform used to develop precision oncology drugs at the Vancouver Prostate Centre (VPC) has been repurposed to shave significant time off the process of finding a cure for COVID-19.
Researchers at the Centre are optimistic that their novel work will provide a list of potential treatment options within a matter of weeks, once they secure the funding needed to do more screening and testing.
In response to the rapidly emerging COVID-19 global health emergency, Dr. Cherkasov's group has utilized their novel AI-based platform, Deep Docking (DD), with the recently published structure of the COVID-19 Mpro target. They applied DD to process 1.3 billion compounds and within a week had identified the top 1000 potential ligands.
Without AI augmentation, this same work would have taken up to three years.
VCHRI News has featured an article discussing Dr. Flannigan's study of getting prostate cancer patients into a regular exercise routine, with an ongoing study of whether this changes the genetic expression and molecular makeup of their tumor and improves their diagnosis.
Click here to read at VCHRI News; text of the article is below.
Congratulations to Drs. Sorensen and Daugaard on being awarded the Martha’s Better Ewing Sarcoma Treatment (BEST) Grant from St. Baldrick’s Foundation: $1,297,000 ($975,000 US) over the next three years to tackle Ewing sarcoma, an aggressive bone and soft tissue cancer in children and young adults.
Click here to read the UBC Faculty of Medicine News story; the text is also posted below.
A recent interview with Dr. Wyatt discussing cell free DNA and circulating tumour DNA in cancer diagnosis has been posted by UroToday. Click here for the interview video and transcript, which was recorded at the 26th Annual Prostate Cancer Foundation Scientific Retreat.
Dr. Amina Zoubeidi has been awarded a five-year CIHR Project grant in the Fall 2019 competition, with her proposal receiving a score of 96%.
The role of the lineage oncogene ASCL1 in treatment-induced neuroendocrine prostate cancer
Principal Investigator: Dr. Amina Zoubeidi
Co-investigators: Dr. Alastair Davies and Dr. Faraz Hach
VCHRI News has featured an article discussing the translational cancer research in Dr. Daugaard's lab investigating a new therapy for childhood solid tumours.